Renal SWE as a Predictor After Pediatric Pyeloplasty for UPJO (UPJO-SWE)

May 28, 2026 updated by: Hany Fathy Badawy, MD, Beni-Suef University

Renal Cortical Shear Wave Elastography as a Predictor of Functional Recovery After Open Pyeloplasty for Unilateral Pediatric Ureteropelvic Junction Obstruction: A Prospective Cohort Study

Ureteropelvic junction obstruction is an important cause of hydronephrosis and potentially reversible renal functional impairment in children. Although open pyeloplasty is an effective standard treatment, the degree of postoperative renal functional recovery varies between patients.

This prospective observational cohort study will evaluate whether renal cortical shear wave elastography can predict renal functional recovery after open pyeloplasty in children with unilateral primary ureteropelvic junction obstruction. Renal cortical shear wave elastography will be assessed before surgery and during follow-up, and the change in elastography values will be compared with renal isotope findings after surgery.

The primary objective is to evaluate the predictive value of the change in renal cortical shear wave elastography from baseline to 3 months after surgery for isotope-defined renal functional recovery at 6 months after open pyeloplasty.

Study Overview

Detailed Description

This is a prospective longitudinal observational cohort study conducted at the Department of Urology, Faculty of Medicine, Beni-Suef University.

The study will include children aged 6 months to 18 years with unilateral primary ureteropelvic junction obstruction who are scheduled for open dismembered pyeloplasty. Eligible children will undergo standard preoperative clinical assessment, laboratory investigations, renal ultrasonography, renal cortical shear wave elastography, and renal isotope assessment.

Preoperative imaging will include renal ultrasonography to assess hydronephrosis, anteroposterior pelvic diameter, and renal cortical thickness. Renal cortical shear wave elastography will be performed to measure cortical stiffness in the affected kidney. Renal isotope assessment will include diuretic renography for differential renal function and drainage assessment, with renal cortical scintigraphy when clinically indicated according to the approved protocol.

All included patients will undergo open dismembered pyeloplasty according to standard surgical principles. Postoperative follow-up will include clinical assessment, renal ultrasonography, and renal cortical shear wave elastography at 3 and 6 months. A repeat renal isotope study will be performed at 6 months after surgery to reassess differential renal function and drainage.

The primary outcome is the predictive performance of the change in renal cortical shear wave elastography from baseline to 3 months postoperatively for 6-month isotope-defined renal functional recovery after pyeloplasty. Secondary outcomes include the association between 3-month postoperative shear wave elastography and functional recovery, longitudinal changes in shear wave elastography, postoperative changes in differential renal function and drainage parameters, and improvement in ultrasonographic parameters after pyeloplasty.

Study Type

Observational

Enrollment (Estimated)

84

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Beni Suweif Governorate
      • Banī Suwayf, Beni Suweif Governorate, Egypt
        • Recruiting
        • Department of Urology- Beni-Suef University Hospitals
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Children aged 6 months to 18 years with unilateral primary ureteropelvic junction obstruction who are scheduled for open dismembered pyeloplasty at the Department of Urology, Faculty of Medicine, Beni-Suef University.

Description

Inclusion Criteria:

  • Children aged 6 months to 18 years.
  • Diagnosis of unilateral primary ureteropelvic junction obstruction.
  • Planned for open dismembered pyeloplasty.
  • Availability of preoperative renal ultrasonography, renal cortical shear wave elastography, and diuretic renography.
  • Written informed consent obtained from parent or legal guardian.

Exclusion Criteria:

  • Bilateral ureteropelvic junction obstruction.
  • Secondary ureteropelvic junction obstruction.
  • Previous ipsilateral upper urinary tract surgery.
  • Associated major urinary tract anomalies likely to independently affect renal function, including vesicoureteral reflux, megaureter, duplex system, posterior urethral valves, or ectopic kidney.
  • Active urinary tract infection at the time of assessment.
  • Known intrinsic renal parenchymal disease unrelated to obstruction.
  • Inability to obtain reliable shear wave elastography measurements.
  • Incomplete planned follow-up.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Children With Unilateral UPJO Undergoing Open Pyeloplasty
Children aged 6 months to 18 years with unilateral primary ureteropelvic junction obstruction scheduled for open dismembered pyeloplasty. Participants will undergo preoperative renal ultrasonography, renal cortical shear wave elastography, and renal isotope assessment, followed by postoperative clinical, ultrasound, shear wave elastography, and isotope follow-up according to the study protocol.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Predictive Accuracy of 3-Month Change in Renal Cortical SWE for 6-Month Functional Recovery
Time Frame: Baseline to 6 months after open pyeloplasty
The change in renal cortical shear wave elastography from baseline to 3 months after open pyeloplasty will be evaluated for its ability to predict renal functional recovery at 6 months.
Baseline to 6 months after open pyeloplasty

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Association Between 3-Month Renal Cortical SWE and 6-Month Functional Recovery
Time Frame: 3 months to 6 months after open pyeloplasty
The association between the renal cortical shear wave elastography value measured at 3 months after open pyeloplasty and renal functional recovery at 6 months will be assessed.
3 months to 6 months after open pyeloplasty
Association Between 6-Month Change in Renal Cortical SWE and 6-Month Isotope Findings
Time Frame: Baseline to 6 months after open pyeloplasty
The change in renal cortical shear wave elastography from baseline to 6 months after open pyeloplasty will be assessed in relation to 6-month renal isotope findings.
Baseline to 6 months after open pyeloplasty
Longitudinal Change in Renal Cortical SWE After Pyeloplasty
Time Frame: Baseline, 3 months, and 6 months after open pyeloplasty.
Renal cortical shear wave elastography values will be compared over time at baseline, 3 months, and 6 months after open pyeloplasty to assess postoperative changes in renal
Baseline, 3 months, and 6 months after open pyeloplasty.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Ultrasonographic Anteroposterior Pelvic Diameter
Time Frame: Baseline, 3 months, and 6 months after open pyeloplasty
Anteroposterior pelvic diameter of the affected kidney will be measured by renal ultrasonography before surgery and during postoperative follow-up to assess improvement in hydronephrosis.
Baseline, 3 months, and 6 months after open pyeloplasty

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hany F Badawy, Faculty of medicine, BeniSuef University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 6, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

May 1, 2027

Study Registration Dates

First Submitted

May 28, 2026

First Submitted That Met QC Criteria

May 28, 2026

First Posted (Actual)

June 3, 2026

Study Record Updates

Last Update Posted (Actual)

June 3, 2026

Last Update Submitted That Met QC Criteria

May 28, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FMBSUREC05052026BadawySWE
  • FMBSUREC/05052026/Badawy (Other Identifier: FM-BSU REC)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared. Only aggregated, de-identified study results will be reported. Individual-level pediatric clinical and imaging data will remain confidential and will be accessible only to the study investigators and authorized regulatory or ethics committee representatives if required.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ureteropelvic Junction Obstruction

Subscribe